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One of the most intriguing phenomena about metazoan cells, as opposed to unicellular eukaryotes, is that their survival depends on not only sufficient surrounding nutrients but also growth factors (71) . When binding to their cognate receptors on the cell surface, growth factors facilitate cellular anabolic metabolism by stimulating the uptake and usage of nutrients such as glucose (119, 123) , amino acids (96) , and glutamine (124) through the translocalization or upregulation of nutrient transporters onto the cell surface. Growth factors exert their growthstimulating roles by activating various signaling pathways, among which the phosphoinositide 3-kinase (PI3K)-AKT pathway appears to play a dominant role. Together, these effects maintain cell energy supply and biosynthesis of various intermediates like nucleotides, amino acids, and fatty acids, which prepare cells for the needs of rapid proliferation, including embryonic development (68) , wound healing (3, 126) , and cancer progression (128) . Not surprisingly, some cells become cancerous after acquiring mutations or altered expression of growth factor signaling-related molecules to engender a state that mimics constant growth factor input and thus sustains dysregulated nutrient uptake and metabolism (63, 118) .
Upon growth factor deprivation, cells begin to use intracellular resources to meet the basic requirements of energy and metabolites, a process known as catabolic metabolism, in that autophagy is a critical one (56, 93, 109) . Autophagy is typically classified into three types, microautophagy, chaperone-mediated autophagy, and macroautophagy. Microautophagy is the direct engulfment of cytosol components by lysosome membrane (84) , and chaperone-mediated autophagy occurs when proteins are specifically recognized by chaperone heat shock cognate 70 (hsc70) and subsequently transferred to lysosome and degraded (46) . Most of our current knowledge about growth factor-related autophagy, however, comes from the study of macroautophagy (56, 93, 134, 135) . Defined as a self-degradation process in that cytosolic components, including unnecessary organelles, are engulfed inside the double-membraned vesicle named autophagosome and subsequently degraded after the autophagosome fuses with the lysosome, macroautophagy (hereafter referred to as autophagy) benefits cell survival under multitudes of stress conditions, such as glucose starvation (47), amino acids depletion (88) , treatment of cytotoxic stressors (95) , infection of pathogens (60) , hypoxia (36), and growth factor deprivation (69) . In the past few decades, extensive studies in yeast and multicellular organisms alike have revealed a great number of genes related to autophagy (86, 134, 135) . The multiple roles of autophagy in cell growth (122) , embryonic development (1, 101, 114, 142) , postnatal survival (57), glucose and lipid homeostasis (2, 31, 106, 141) , and cancer progression (13, 14, 127) were also demonstrated. Although the core autophagy-related genes (the ATG genes) are highly conserved from yeast to mammals (132) , growth factor deprivation-induced autophagy seems to be specific for metazoans since unicellular organisms lack the growth factor-dependent nutrients uptake system (71) , which hints at the possibility that mammalian cells probably own a more sophisticated autophagy machinery network (4, 134, 135) . Indeed, different stimuli are capable of using different pathways to elicit autophagy in mammals (12, 56, 90) .
Early work by several independent groups of researchers on the negative regulatory functions of growth factors in autophagy opened up new avenues to studying the growth factor-related autophagy. For example, Kondo and colleagues found that inhibition of platelet-derived growth factor signaling was able to induce autophagy in malignant glioma cells (110) . Using C. elegans as a model system, it was depicted that autophagy is suppressed upon insulin-like growth factor activation (83) . In another study, removal of single IL-3 from the culture medium was shown to be capable of inducing autophagy in apoptosis-lacking cells (69) . It is also noteworthy that some growth factors such as TGF-␤ and TGF-␣ could reversely stimulate autophagy under certain conditions (42, 49) . However, these positive regulatory roles of the TGF factors in autophagy induction are often associated with their growth-inhibitory side rather than the growthstimulating effects referred to herein. Therefore, it is probably safe to conclude that growth (stimulating) factors are intrinsic autophagy suppressors (71) .
Growth Factor-Regulated Autophagy as a Gatekeeper for Maintaining Cellular Homeostasis
In multicellular organisms, cellular metabolism is under delicate regulatory control instructed by growth factor signaling. Unlike unicellular organisms, metazoan cells compete for limiting growth factors (94) . Without stimulation of growth factors, cells are reprogramed to downregulate the major anabolic processes and adopt a catabolic metabolism designed to maximize the efficiency of ATP production from limited nutrient uptake (18, 69, 71, 102, 118) . Growing lines of evidence demonstrate that such loss of nutrient usage can directly affect some crucial intracellular processes; for example, decrease in the levels of intermediate metabolites such as acetyl-CoA, a substrate for global histone acetylation, leads to downregulated expression of anabolic enzymes (70, 123, 144) .
Under the situation of growth factor restriction, autophagy plays a major role in providing cells with amino acids and lipids for the catabolic processes initiated to support the demand of ATP and thus sustain cellular homeostasis. By digesting their own macromolecules such as proteins and organelles, cells cannot only obtain copious substrates for both biosynthesis and energy generation but also eliminate damaged organelles or misfolded proteins and, therefore, to some extent prevent the generation of excess ROS and genome instability (56, 85, 93) . The importance of autophagy in facilitating cell survival is also underscored by the observation that deletion of certain autophagy-related genes leads to a much rapid death of cells under growth factor-deprivation conditions (69) . Altogether, upon growth factor restriction, cells are forced to shut down almost all of the proliferation-related pathways and stop most of the anabolic processes, which is followed by the cell cycle arrest and catabolic processes such as oxidation of macromolecules and autophagy (118, 121, 122) , although prolonged withdrawal of growth factors will indeed lead to cell death (15) (FIGURE 1).
Conversely, after replenishment of growth factors, cells shift the main challenge from survival back to growth and proliferation, and initiate anabolic metabolism (125) . The instructive growth factor signaling therefore redirects cells to increase the uptake of glucose, glutamine, and the other nutrients to directly support the anabolic requirement for cell proliferation and suppress autophagy in the meantime (69) .
Relationship Between Autophagy and Apoptosis on Growth Factor Restriction
Over the recent years, with the help of genetic tools to disable the autophagic machinery, it is becoming more evident that, rather than a mechanism to execute cell death, autophagy represents an antiapoptosis process and promotes cell survival under various stimuli (54, 55, 138, 104) . Especially, with the loss of growth factor signals, the uptake of nutrients are limited (96, 119, 123, 124) and autophagy is subsequently strongly activated (64, 69, 145) . By breaking down cellular components and recycling metabolic substrates, autophagy at such conditions becomes the major force to maintain regular energy homeostasis inside the cell (71, 93) . However, as more and more cellular contents are recycled through autophagy, there is an expected time point that cellular components are depleted. Apoptosis or other cell death procedures, therefore, gradually become the major theme as the restriction of growth factor continues (73) (FIGURE 1). It is also noteworthy that autophagy and apoptosis probably often occur at the same time as they compete to determine cell fate, the concept of which is further strengthened by the fact that some molecules are even shared by these two different processes (73, 89) .
The Signaling Network of Growth Factor Restriction-Induced Autophagy
Researchers have revealed elaborate signaling networks that regulate growth factor-related autophagy (FIGURE 2). The protein kinase AKT is a central node linking growth factors to induction of autophagy. Several pathways act upstream of AKT to mediate growth factor signaling through distinct routes (6) . Lack of growth factor signaling often leads to reduced AKT activity, which by default renders AKT target substrates de-inhibited (32, 75). Over 100 nonredundant AKT substrates, including TSC2 (26, 27, 111) , the forkhead box (FOX) O transcription factors 1/3/4 (91, 113), GSK3␣/␤ (16), and Beclin 1, have been reported to execute diverse biological functions (75) . Importantly, these factors are the major mediators for AKT to regulate growth factor-related autophagy.
Upstream Signaling to AKT
Cells sense the abundance of extracellular growth factors through a series of ligand-specific receptor tyrosine kinases (RTKs) (62) . There are ϳ20 subfamilies of RTKs in humans, all of which share a common structure consisting of an extracellular ligand-binding region, a single-pass transmembrane domain, and an intracellular tyrosine kinase domain. In most cases, binding of a growth factor to the ligand-binding domain of its cognate receptor results in the activation of this receptor kinase and initiation of intracellular signaling cascades, which manifests various cellular effects (62) . Insulin and insulin-like growth factor I (IGFI), for example, activate their cognate receptors that, in turn, phosphorylate adaptor proteins such as insulin receptor substrate (IRS) and Src homologous and collagen (SHC) proteins, and the activated IRS or SHC consequently leads to activation of the PI3K-AKT pathway and MAPK cascade (6, 8) . Similarly, other growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF) activate their respective receptors through phosphorylation of their cytoplasmic tails, which recruit specific effector molecules such as SHP-2, Gab1, and Grb2 and further activate the PI3K-AKT signaling (8, 130, 136) .
Downstream Signaling of AKT mTOR
mTOR is an evolutionarily conserved serine/threonine protein kinase that controls cell metabolism and growth (20, 41, 59) . Regulated by a variety of upstream signals, mTOR is strongly repressed by tuberous sclerosis 2 (TSC2; also known as tuberin) and proline-rich AKT substrate 40 kDa (PRAS40) (27, 37, 99, 111, 117) . Upon growth factor restriction, AKT, along with other growth factor responding kinases such as MAPK and p90RSK1, no longer phosphorylates and inactivates TSC2 (26, 27, 76, 92) and PRAS40 (53) , which hence leads to the inhibition of mTOR. Such suppressed mTOR then activates autophagy due to its impaired ability to phosphorylate and inhibit the ULK1/ATG13/FIP200 (unc-51-like kinase 1/mammalian autophagy-related gene 13/focal adhesion kinase family-interacting protein of 200 kDa) complex that belongs to the autophagy initiation core machinery (25, 35, 45) . In addition, mTOR is also implicated to suppress autophagy during the step of lysosome activation (146) .
GSK3
GSK3 is one of the most classic AKT substrates (16) . The activity of GSK3 is inversely regulated by phosphorylation by AKT; in other words, in the absence of AKT activity, GSK3 becomes active after deinhibition. In addition to common growth factors, developmental morphogens that promote cell growth, such as Wnt and hedgehog ligands, also participate in the regulation of autophagy by modulating GSK3 activity (43, 105, 131) . This feature makes GSK3 an inherent sensor for the abundance of a large variety of growth factors. GSK3 can phosphorylate TSC2, leading to mTOR inactivation (38) . Direct inhibition of GSK3 by specific chemical inhibitors attenuates autophagy, which was proposed to be due to mTOR being activated (100). Another pivotal direct target of GSK3 for the regulation of growth factor-related autophagy is the acetyltransferase TIP60, also known as K (lysine)-acetyltransferase 5 or KAT5. Upon growth factor deprivation, de-inhibited GSK3 phosphorylates and increases the enzymatic activity of TIP60, which in turn acetylates and activates ULK1, leading to autophagy initiation (64) . Genetic hints for the emerging roles of TIP60 (Esa1 in yeast) as an essential autophagy regulator was also obtained in yeast and fruit flies (58, 137) . In support of a positive role of GSK3 in autophagy, it was demonstrated that interleukin 17A inhibits autophagy through inactivating GSK3␤ (66) , and activation of GSK3 by ROS was shown to promote autophagy (67) .
FOXO
Apart from regulation of signaling molecules, growth factor-stimulated AKT can directly phosphorylate the forkhead box (FOX) O transcription factors, which are consequently excluded from the nucleus and inactivated (7, 50) . In the absence of growth factors, decreased PI3K-AKT signaling leads to increased transcriptional activity of FOXO3, inducing the expression of several core autophagy genes, such as LC3B and Gabarapl1 (19, 74, 103, 143) . Interestingly, it was shown that the AKT-FOXO3 axis is involved in autophagy induction in skeletal muscle (74) , and instead inhibition of mTOR by rapamycin is not able to initiate this process. These findings suggest that selective usages of the distinct signaling cascades may exist in different cells or tissues. In addition to direct transactivation of the autophagy core molecules, FOXO could upregulate glutamine synthetase for glutamine production, which results in mTOR inhibition and ultimately autophagy induction (116) . Of note, a transactivation-independent mechanism for FOXO has been suggested by a report showing that, under serum starvation conditions, cytosolic FOXO1 became heavily acetylated after dissociating from histone deacetylase SIRT2 and in turn bound to ATG7 to promote autophagy (145), although it was disputed that, upon activation, FOXO1 is mostly translocated into the nucleus (82).
Beclin 1
Moreover, the core autophagy machinery has also been shown to be directly targeted by AKT. Wang et al. (120) demonstrated that AKT directly phosphorylates Beclin 1, a Bcl-2 interacting coiled-coil protein, and the mammalian othologue of yeast Atg6, leading to dissociation of the autophagy-activating Beclin 1-VPS34 complex and inhibition of autophagy.
AMPK
AMPK is the major sensor of cellular energy status and is implicated as critical in glucose starvationinduced autophagy (21, 30, 47) . In response to acute energy depletion caused by hypoxia, exercise, or glucose deprivation, AMPK is activated by phosphorylation at Thr172, which is mainly catalyzed by the liver kinase B1 (LKB1) (30) . Not surprisingly, upon glucose deprivation, AMPK activates ULK1 through
FIGURE 2. Signaling network of growth factor restriction-induced autophagy
The protein kinase AKT is a central node linking growth factor signaling to downstream pathways that related to autophagy induction. In the presence of growth factors, AKT phosphorylates a wide array of substrates, including TSC2, PRAS40, GSK3, FOXO, and Beclin 1, leading to their inactivation. Conversely, growth factor restriction could result in de-inhibition of these substrates and subsequent initiation of autophagy through different pathways. phosphorylation and induces autophagy (21, 47) , but what about the growth factor restriction conditions? AKT signaling, in the stimulation of insulin, negatively regulates the Thr172 phosphorylation of cardiac AMPK (34, 52). In addition, under Wnt stimulation, AMPK phosphorylates TSC2, suppressor of mTOR (38) . However, as our previous work demonstrated, even prolonged growth factor deprivation, different from glucose starvation, did not seem to activate AMPK-ULK1 pathway in MEFs (64) . The effects of growth factors on AMPK activation and its ability in autophagy induction upon growth factor deprivation therefore probably require more indepth investigation under different tissues and stimulation situations.
Pathophysiological Functions of Growth Factor-Related Autophagy
Autophagy is now widely implicated in pathophysiological processes such as cancer, neurodegenerative disorders, aging, and cardiovascular and pulmonary diseases (14) . Below, we will focus on the possible roles of growth factor-related autophagy as a pathophysiogical mediator and potential target for therapeutic intervention (FIGURE 3) .
Increasing evidence supports the claim that autophagy is a double-edged sword in tumorigenesis (14, 48, 65, 127) . On one hand, autophagy has been depicted to be capable of guarding against tumorigenesis by processes such as limiting inflammation, eliminating toxic unfolded proteins, and removing damaged mitochondria that may produce cytotoxic reactive oxygen species (28, 79, 80, 127) . Loss of autophagy by genetically targeting core autophagy machinery is also reported to result in tumor development (77, 108, 140) . Recently, direct evidence linking the loss of growth factorrelated autophagy to cancer development has been shown (51, 120) . Furthermore, since cancer cells often gain mutations of the critical regulators in growth factor-sensing machineries, such as PIK3CA, AKT, PTEN, TSC2, and Ras, they display constitutive cell proliferation independent of growth factors. Importantly, the mutations may dampen autophagy activity. It remains to be seen whether lack of autophagy in the settings of oncogenic mutations would facilitate cancer development or progression (5, 17, 33, 44, 107, 139, 147) .
On the other hand, autophagy may also endow the cancer cells with the ability to survive in nutrient-poor conditions through multiple processes (9, 10, 23, 29) . Suppression of autophagy hence conversely renders cancer cell more apt to death. For instance, Yang et al. reported that inhibition of autophagy leads to a robust tumor regression and prolonged survival in pancreatic cancer xenografts and genetic mouse models (133) . Moreover, in Tsc2-null cells, which exhibit high mTOR activity and likely own low autophagy activity, are hypersentitive to energy deprivation-induced apoptosis (39) . Such phenomena have been especially instructive for cancer therapy since tumor cells exposed to traditional radio-or chemotherapy often activate autophagy to promote survival and become resistant to these treatments. Blockage of autophagy is therefore considered as a promising complementary way to promote cancer cell death and to improve patient survival during clinical cancer therapy (112) .
Many studies have implicated autophagy in the aging process. Genetic inhibition of autophagy induces aging-like degenerative changes in mammalian tissues, and that pathological aging, and normal aging alike, is often associated with a reduced autophagic potential (78, 97) . The longevitypromoting effect of autophagy could probably be reached through several ways. First of all, the accumulation of misfolded or aggregated proteins, like beta-amyloid and damaged organelles, which strongly facilitate the aging process, can be effectively prevented through autophagy (19, 26, 40, 129) . Second, autophagy could also reduce inflammatory cytokine secretion and spontaneous tumor incidence (72, 98) . Furthermore, consistent with a correlation between autophagy and aging, aging is demonstrated to be negatively associated with serum concentrations of several growth factors and anabolic hormones. For example, the circulating levels of GH, IGF-I, sex hormones, and DHEAs progressively decline between 20 and 80 years of age in humans (61) . Finally, artificially stimulating growth factor-related autophagy pathways has recently been shown to promote longevity in different model systems. For example, the FOXO family, which is a direct executor in growth factor signaling and a classic autophagy stimulator, has been widely recognized as an aging promoter in both yeast and other organisms (22, 115) . In another study using cardiomyocytes as a model system, specific expression of dominant-negative PI3K, which also activates autophagy, leads to reduced lipofuscin levels in the heart and increased longevity (24, 40) . Thus manipulation of growth factorrelated autophagy could be a potential way to delay aging.
Suppression of autophagy has also been shown to be a potential therapy for some diseases that are caused, at least in part, as a result of dysregulated autophagy. Recognized as one of the leading causes of infant mortality, necrotizing enterocolitis (NEC) is a common but devastating gastrointestinal disease primarily seen in premature infants (87) . The pathogenesis of this disorder is not fully understood, yet it probably involves over-induction of autophagy. Maynard et al. demonstrated that admission of epidermal growth factor (EGF) could strongly block the autophagy activity in the intestinal epithelium from patients with NEC and reduce the death rate of epithelial cells, leading to protection of the intestinal epithelium against mucosal injury (81) .
Conclusions and Perspectives
The past few decades have witnessed tremendous advances in our knowledge of autophagy, both in its molecular mechanisms and its pathophysiological functions. Activated by various stimuli, autophagy has been considered as one of the most important links between availability of extracellular nutrients and intracellular metabolism. In mammalian cells, such a link is heavily dependent on the availability of growth factors. Despite the delineation of the AKT-mTOR-ULK1, AKT-GSK3-ULK1, and AKT-FOXO signaling routes, much has to be learned about the molecular mechanisms and functions of autophagy induced by limited growth factors. One of the major challenges is to determine how these different signaling modes are preferentially utilized in response to limitation of growth factors or extracellular nutrients, although AKT activity may play a general upstream role in controlling the activity of GSK3, mTOR, and FOXO. For instance, Goldberg and colleagues demonstrated that AKT-FOXO route rather than AKTmTOR route is adopted in muscle autophagy (143) . In our study, the GSK3-TIP60-ULK1 route seems to have no contribution to the glucose deprivationinduced autophagy (64) .
Equally puzzling is how the distinct pathways cross talk to each other. Preliminary work has implicated interrelationships between components of these distinct pathways. Inoki et al. demonstrated that GSK3 and AMPK cooperatively phosphorylate TSC2 and inhibit mTOR (38) . Activation of FOXO could also inhibit mTOR by elevating glutamine production (116) . In addition, upon stimulation by DNA damage, GSK3-TIP60 axis acetylates and activates p53 (11) , which shares a wide array of transcription targets with FOXO. Whether p53 activation by GSK3-TIP60 is also utilized in growth factor-related autophagy remains to be tested.
What other mechanisms may be associated with the individual components that participate in these pathways is another interesting question. TIP60, for example, is the key component in a transcription co-regulator complex, acting for a range of transcription factors. Does it have any role resembling the one FOXO played in changing the transcriptional programs in cells induced to undergo autophagy? Furthermore, although cells do undergo death after prolonged growth factor deprivation (15), little is known about how the stressed cells exactly die. The molecular switch controlling the fate of the cells to live or to die deserves to be established. There is no doubt that understanding of these open questions will be enormously beneficial in providing effective therapeutic approaches for detection, treatment, and control of diseases caused by altered growth factor-related autophagy. Ⅲ 
